Cadre Holdings, Inc. (NYSE:CDRE – Get Free Report) CEO Warren B. Kanders sold 25,000 shares of the business’s stock in a transaction dated Thursday, December 5th. The shares were sold at an average price of $35.83, for a total transaction of $895,750.00. Following the completion of the sale, the chief executive officer now directly owns 11,532,211 shares of the company’s stock, valued at approximately $413,199,120.13. This trade represents a 0.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Cadre Trading Down 0.8 %
NYSE:CDRE opened at $35.01 on Wednesday. Cadre Holdings, Inc. has a one year low of $29.18 and a one year high of $40.28. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.96 and a current ratio of 3.01. The firm has a market cap of $1.42 billion, a P/E ratio of 42.18, a P/E/G ratio of 2.10 and a beta of 1.24. The firm has a 50-day simple moving average of $35.85 and a 200-day simple moving average of $35.20.
Cadre (NYSE:CDRE – Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.06 by $0.03. Cadre had a net margin of 6.34% and a return on equity of 12.88%. The business had revenue of $109.41 million during the quarter, compared to analyst estimates of $126.27 million. During the same quarter in the previous year, the business posted $0.29 EPS. The company’s quarterly revenue was down 12.6% compared to the same quarter last year. Equities analysts anticipate that Cadre Holdings, Inc. will post 1.05 EPS for the current fiscal year.
Cadre Announces Dividend
Wall Street Analyst Weigh In
Separately, Roth Mkm lowered their price objective on shares of Cadre from $39.00 to $37.00 and set a “buy” rating for the company in a research report on Thursday, November 7th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, Cadre currently has an average rating of “Moderate Buy” and a consensus target price of $39.75.
View Our Latest Analysis on CDRE
Institutional Investors Weigh In On Cadre
Large investors have recently modified their holdings of the business. Harel Insurance Investments & Financial Services Ltd. raised its stake in shares of Cadre by 454.3% during the 2nd quarter. Harel Insurance Investments & Financial Services Ltd. now owns 1,624 shares of the company’s stock worth $55,000 after acquiring an additional 1,331 shares in the last quarter. Canada Pension Plan Investment Board bought a new position in shares of Cadre during the 2nd quarter worth approximately $141,000. Franklin Resources Inc. bought a new position in shares of Cadre during the 3rd quarter worth approximately $208,000. Truist Financial Corp bought a new position in shares of Cadre during the 2nd quarter worth approximately $209,000. Finally, Oppenheimer Asset Management Inc. bought a new position in shares of Cadre during the 2nd quarter worth approximately $216,000. Institutional investors own 43.95% of the company’s stock.
Cadre Company Profile
Cadre Holdings, Inc manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products.
Featured Articles
- Five stocks we like better than Cadre
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- Stock Average Calculator
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for Cadre Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cadre and related companies with MarketBeat.com's FREE daily email newsletter.